173 related articles for article (PubMed ID: 25409302)
1. Overexpression of Mcl-1L splice variant is associated with poor prognosis and chemoresistance in oral cancers.
Palve V; Mallick S; Ghaisas G; Kannan S; Teni T
PLoS One; 2014; 9(11):e111927. PubMed ID: 25409302
[TBL] [Abstract][Full Text] [Related]
2. Association of anti-apoptotic Mcl-1L isoform expression with radioresistance of oral squamous carcinoma cells.
Palve VC; Teni TR
Radiat Oncol; 2012 Aug; 7():135. PubMed ID: 22873792
[TBL] [Abstract][Full Text] [Related]
3. [Role of overexpression of myeloid cell leukemia-1-long in prognosis of malignant pleomorphic adenoma].
Hao JQ; Fan XH; Li JY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Mar; 55(3):153-158. PubMed ID: 32193910
[No Abstract] [Full Text] [Related]
4. Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1.
Mallick S; Patil R; Gyanchandani R; Pawar S; Palve V; Kannan S; Pathak KA; Choudhary M; Teni TR
J Pathol; 2009 Feb; 217(3):398-407. PubMed ID: 19009587
[TBL] [Abstract][Full Text] [Related]
5. MCL-1 dependency of cisplatin-resistant cancer cells.
Michels J; Obrist F; Vitale I; Lissa D; Garcia P; Behnam-Motlagh P; Kohno K; Wu GS; Brenner C; Castedo M; Kroemer G
Biochem Pharmacol; 2014 Nov; 92(1):55-61. PubMed ID: 25107702
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
7. MCL-1 is the key target of adjuvant chemotherapy to reverse the cisplatin-resistance in NSCLC.
Ma J; Zhao Z; Wu K; Xu Z; Liu K
Gene; 2016 Aug; 587(2):147-54. PubMed ID: 27138804
[TBL] [Abstract][Full Text] [Related]
8. Alcohol-Mediated Missplicing of Mcl-1 Pre-mRNA is Involved in Neurotoxicity.
Sariyer R; De-Simone FI; Donadoni M; Hoek JB; Chang SL; Sariyer IK
Alcohol Clin Exp Res; 2017 Oct; 41(10):1715-1724. PubMed ID: 28800142
[TBL] [Abstract][Full Text] [Related]
9. The pan-Bcl-2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells.
Peter B; Cerny-Reiterer S; Hadzijusufovic E; Schuch K; Stefanzl G; Eisenwort G; Gleixner KV; Hoermann G; Mayerhofer M; Kundi M; Baumgartner S; Sperr WR; Pickl WF; Willmann M; Valent P
J Leukoc Biol; 2014 Jan; 95(1):95-104. PubMed ID: 24052572
[TBL] [Abstract][Full Text] [Related]
10. MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain.
Bae J; Leo CP; Hsu SY; Hsueh AJ
J Biol Chem; 2000 Aug; 275(33):25255-61. PubMed ID: 10837489
[TBL] [Abstract][Full Text] [Related]
11. MCL-1ES, a novel variant of MCL-1, associates with MCL-1L and induces mitochondrial cell death.
Kim JH; Sim SH; Ha HJ; Ko JJ; Lee K; Bae J
FEBS Lett; 2009 Sep; 583(17):2758-64. PubMed ID: 19683529
[TBL] [Abstract][Full Text] [Related]
12. Alcohol exposure alters pre-mRNA splicing of antiapoptotic Mcl-1L isoform and induces apoptosis in neural progenitors and immature neurons.
Donadoni M; Cicalese S; Sarkar DK; Chang SL; Sariyer IK
Cell Death Dis; 2019 Jun; 10(6):447. PubMed ID: 31171771
[TBL] [Abstract][Full Text] [Related]
13. MiR-363 sensitizes cisplatin-induced apoptosis targeting in Mcl-1 in breast cancer.
Zhang R; Li Y; Dong X; Peng L; Nie X
Med Oncol; 2014 Dec; 31(12):347. PubMed ID: 25416050
[TBL] [Abstract][Full Text] [Related]
14. Modification of alternative splicing of Mcl-1 pre-mRNA using antisense morpholino oligonucleotides induces apoptosis in basal cell carcinoma cells.
Shieh JJ; Liu KT; Huang SW; Chen YJ; Hsieh TY
J Invest Dermatol; 2009 Oct; 129(10):2497-506. PubMed ID: 19369967
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Mcl-1 alternative splicing by hnRNP F, H1 and K in breast cancer cells.
Tyson-Capper A; Gautrey H
RNA Biol; 2018; 15(12):1448-1457. PubMed ID: 30468106
[TBL] [Abstract][Full Text] [Related]
16. Elevated USP9X drives early-to-late-stage oral tumorigenesis via stabilisation of anti-apoptotic MCL-1 protein and impacts outcome in oral cancers.
Sulkshane P; Pawar SN; Waghole R; Pawar SS; Rajput P; Uthale A; Oak S; Kalkar P; Wani H; Patil R; Nair S; Rane P; Teni T
Br J Cancer; 2021 Aug; 125(4):547-560. PubMed ID: 34079080
[TBL] [Abstract][Full Text] [Related]
17. Mcl-1 targeting could be an intriguing perspective to cure cancer.
De Blasio A; Vento R; Di Fiore R
J Cell Physiol; 2018 Nov; 233(11):8482-8498. PubMed ID: 29797573
[TBL] [Abstract][Full Text] [Related]
18. Expression of Mcl-1 splicing variants in clear-cell renal cancer and their correlation with histopathological parameters and prognosis.
Kempkensteffen C; Hinz S; Johannsen M; Krause H; Magheli A; Christoph F; Köllermann J; Schrader M; Schostak M; Miller K; Weikert S
Tumour Biol; 2009; 30(2):73-9. PubMed ID: 19401626
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
[TBL] [Abstract][Full Text] [Related]
20. STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma.
Maji S; Shriwas O; Samal SK; Priyadarshini M; Rath R; Panda S; Das Majumdar SK; Muduly DK; Dash R
Carcinogenesis; 2019 Mar; 40(1):173-183. PubMed ID: 30395230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
